Cargando…
Challenges in Using Circulating miRNAs as Cancer Biomarkers
In the last years, circulating miRNAs have emerged as a new class of promising cancer biomarkers. Independent studies have shown the feasibility of using these small RNAs as tools for the diagnosis and prognosis of different types of malignancies as well as for predicting and possibly monitoring tre...
Autores principales: | Tiberio, Paola, Callari, Maurizio, Angeloni, Valentina, Daidone, Maria Grazia, Appierto, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385632/ https://www.ncbi.nlm.nih.gov/pubmed/25874226 http://dx.doi.org/10.1155/2015/731479 |
Ejemplares similares
-
Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation
por: Landoni, Elena, et al.
Publicado: (2015) -
AF1q: A Novel Mediator of Basal and 4-HPR-Induced Apoptosis in Ovarian Cancer Cells
por: Tiberio, Paola, et al.
Publicado: (2012) -
Involvement of AF1q/MLLT11 in the progression of ovarian cancer
por: Tiberio, Paola, et al.
Publicado: (2017) -
Methodological challenges in utilizing miRNAs as circulating biomarkers
por: Moldovan, Leni, et al.
Publicado: (2014) -
Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)